Sumatriptan is manufactured by GSK and is used to treat migraines. ## Compulsory licenses Compulsory licenses have been issued for Sumatriptan in the following instance: ### Italy issued on February 01, 2006 [[Italy]]'s provisions on compulsory licences can be in the Intellectual Property Code. There are two possibilities to obtain a compulsory licence, all regulated by the IP Code: - due to lack of exploitation (Art. 70 IPC); - due to dependent patent (Art. 71 IPC, and Art. 81octies IPC regarding biotech and plant varieties pursuant to the implementation of the Biotech Directive). More information can be found [here](https://e-courses.epo.org/wbts_int/CompulsoryLicensing/CL_IT.pdf). However, a compulsory license has not been executed for Sumatriptan in this case because: a voluntary licence and/or data transfer has been agreed as part of a settlement. ## Other products issued by the same manufacturer [[3TC/D4T/NVP]] [[AZT]] [[Sumatriptan]] [[Dolutegravir]] [[3TC/AZT]] [[ABC/3TC]] [[3TC]] ## Other products for the same disease